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Abstract 
Synthesis  of   novel   5-[2- aminoquinazolin-4-one-3-yl]-2- phthalimidomethylthiadiazole   2   from  5-
[2-ethoxyquinazolin-4-one-3-yl]-2-phthalamidomethylthiadiazole  1.    The   behavior   of   2   as  a  
nitrogen nucleophile  towards  an  α-hydroxy-aldehyde,  such as glucose and formation of Amadori  
rearrangement product (ARP) 8 that has had occurred during the course of reaction was discussed. 
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1. I
ntroduction 
In recent years there has been an increasing   interest in the chemistry of  4(3H)-quinazolinone 
derivatives because of their biological importance.  Many of them  show  antifungal (Partoli et al 
1998),  antibacterial (Abdel-Hamid et al 1997), anticancer (Barker 1995), anti-inflammatory (Bakhit et 
al 1998), anticonvulsant (Gursoy et al 1995),  immunotropic (Nawrocka et al 1997),  hypolipidemic 
(Kuroji et al 1996),  antitumor (Hame et al 1996),  antiulcer (Terashima et al 1995),  analgesic 
(Hemalatha et al 2011),   antiproliferative (Raffa et al 1999)  activities  and  inhibitory effects for the 
thymidylate  synthase  and  poly (ADP-ribose) polymerase (PARP) (Baek et al 1998). Some of 4-
anilinoquinazolines have been found to be potential and highly selective inhibitors of human 
immunoglobulin  E (Berger et al 2001) and  epidermal growth  factor receptor  tyrosine kinase (Bridges 
2001) which  regulates  the  cell  growth  and  proliferation, so they can work as potent anti-allergic or 
anti-cancer agents, respectively.   
2. Results and Discussion 
It  is  well known that  cyclic and acyclic nucleosides often enhance the biological activity of 
heterocyclic derivatives  (Wang et al 2010).   Herein   we  synthesized   a   novel   5-[2-
aminoquinazolin-4-one-3-yl]-2-phthalimidomethylthiadiazole from our previously reported biologically 
active quinazolinone 5-[2-ethoxy-quinazolin-4-one-3-yl]-2-phthalamidomethylthiadiazole  (El-Hashash 
et al 2011),  and then discussed and reported its behavior as nitrogen nucleophile towards an  α-hydroxy-
aldehyde, such as glucose. In this paper, it is so important to pay attention to the so-called Amadori 
rearrangement that has had occurred during the course of reaction.   The Amadori reaction, which is the 
first step in  “Maillard browning”  (Maillard 1912, Ibid 1912,  Ledl et al 1990),  is a potential non-
enzymatic way to link reducing  carbohydrates to complex biomolecules with reactive amino groups. 
The Amadori-rearrangement involves the reaction of α-hydroxy-aldehydes with suitable amine leading 
to the corresponding glycosylamine and the following rearrangement to the corresponding ketosamine, 
i.e. the Amadori-rearrangement product (ARP). The early mechanism for the Amadori-rearrangement 
was suggested by Kuhn and Weygand (1937). The initial reaction between the anomeric position of 
glucose  and  amino group  of derivative 2 leads to the formation of glycosylamine 3 (Scheme 1).  After 
the protonation the Schiff base 5 is formed by ring opening, which is in equilibrium with the enol 6. 
This enol is stabilized by the formation of 1-amino-1-deoxyketohexose 7, which undergoes ring closure 
to the corresponding hemiketal 8.  
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(a) HCONH2; (b) glucose 
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Scheme 1: Synthetic pathway of the Amadori rearragement product   8 
 
3. E
xperimental: 
 
General 
All   melting   points   recorded   are  uncorrected.   The   IR  spectra   were   recorded  on  a  Pye  
Unicam  SP 1200  spectrophotometer  using  the  KBr  wafer  technique.   The  1H-NMR  spectra  were  
determined  on a Varian  FT-200, or Bruker AC-200 MHz instrument using TMS as an internal 
standard. The chemical shifts (δ)  are  expressed  in  ppm.  The  mass  spectra  were  determined  using  
MP  model  NS-5988  and  Shimadzu  single  focusing  mass  spectrometer  (70 eV).  All solvents used 
were of HPLC/AnalaR  grade.   All reagents were used as received from Alfa Aesar. 
Synthesis of Compounds  2, 3 and 8 
A mixture of equimolar amounts of 5-[2-ethoxyquinazolin-4(3H)-one-3-yl]-2-
phthalimidomethylthiadiazole 1 and formamide (0.01 mol) was heated under reflux for 5 h. The mixture 
was cooled and then poured onto ice/water with frequent stirring.  The brown solid that separated out 
was filtered, washed with water, dried and crystallized from DMF to afford 2.  Stirring derivative  2  
(0.01 mol)  with  glucose  (3 equivalents) in methanol (25 mL) at 40 oC for 12 h afforded brownish 
white syrupy solid of derivative 3.    Protonation of derivative  3  was achieved by washing with an 
equimolar quantity of dilute hydrochloric acid (0.01 mol), affording light brown precipitate of 4 as the 
hydrochloride form. The presence of halogen was verified by a green flame with a copper wire. 
Treatment of product 4 with sodium bicarbonate solution (0.01 mol each) produced  a  dark  brown  
precipitate  which  was  filtered,   washed  frequently  with  water,   dried  and  then crystallized with DMF 
affording derivative 8. Purification and separation of 8 was achieved using column chromatography 
(3:1 EtOAc: Hexane).       
5-[2-Aminoquinazolin-4(3H)-one-3-yl]-2-phthalamidomethylthiadiazole   2:    Brown crystals from 
DMF; m.p. 303-304 ºC;  yield 85%.  Anal.  for  C19H12N6O3S  (m.w. 404): found: C, 56.55; H, 2.99; N, 
20.84; S, 7.99; Calcd: C, 56.44; H, 2.97; N, 20.79; S, 7.92.  IR υ (cm-1) 1631 (C=N), 1670, 1727, 1776 
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(3xC=O).  MS: m/z  (int. %)  [M+H]+  404 (58.0), 435 (22.8), 245 (36.4), 247 (3.4), 191(100),  193 
(56.1), 186 (78.0), 188 (12.7), 175 (30.1), 177 (8.1), 157 (3.2), 159 (0.1), 147 (8.3), 149 (0.3), 130 
(48.3), 132 (6.4), 122 (4.5), 124 (0.2), 78 (0.3), 80 (0.1);1H-NMR (DMSO-d6)  δ 5.16 (s, 2H; CH2,  
phthalimidomethyl), 7.32-7.86 (m, 4H, quinazolinone), 7.94-8.03 (m, 4H, phthalimido-H), 9.38(bs, 1H, 
NH).     
2-{[(3S, 5S)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]amino}quinazolin-4(3H)-one  3:    
Brownish white syrupy solid from methanol;  m.p. ˃ 300 oC;  yield 80%.  Anal. for  C25H22N6O8S 
(m.w. 566): found: C, 56.48;  H, 3.01;  N, 20.83;  S, 7.96; Calcd: C, 56.44;  H, 2.97;  N, 20.79;  S, 7.92.  IR 
υ (cm-1) 1634 (C=N), 1671, 1724, 1776 (3xC=O). 
 
3-(5-Phthalimidomethyl-1,3,4-thiadiazol-2-yl)-2-{[(2,3,4,5-tetrahydroxytetrahydro-2H-pyran-2-yl)methyl)amino} 
quinazolin-4(3H)-one  8:     Brown crystals from DMF;  m.p. 303-304 ºC; yield 85 %. Anal.  for 
C25H22N6O8S (m.w. 566):   found:  C,  53.06;  H,  3.98;  N,  14.92;  S, 5.72;  Calcd:  C, 53.0;  H, 3.93;  
N, 14.84;  S, 5.65. IR  υ  (cm-1) 1631 (C=N),  1670,  1727, 1776 (3xC=O).  MS: m/z (int. %)  [M+H]+  
566 (58.0),  568 (22.8),  245  (36.4),   247  (3.4),  191  (100),  193  (56.1),  186  (78.0),  188  (12.7),   
175  (30.1),   177  (8.1),  157 (3.2),  159 (0.1),  147  (8.3),  149 (0.3),  130  (48.3),  132  (6.4),  122  
(4.5),  124 (0.2), 78 (0.3),  80  (0.1); 1H-NMR (DMSO-d6)  δ  3.19  (dd,  1H,  pyran-H-4),  3.28  (d,  
1H, pyran-H-3), 3.55 (m, 1H, pyran-H-5), 3.72 (s, 2H, NHCH2),  3.81, 3.87 (2 dd, 2H,  pyran-H-6a,b),  
5.17 (s, 2H,  phthalimido-CH2), 7.31-7.75 (m, 4H, quinazolinone), 7.72-7.88 (m, 4H, phthalimido-H), 
9.42 (br s, 1H, NH). 
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